Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Infection|June 5, 2021
The clinical value of the endocarditis team: insights from before and after guidelines implementation strategyBoaz Elad, Leor Perl, Ashraf Hamdan, et al.
Emerging Infectious Diseases|July 21, 2021
Spotted Fever Group Rickettsioses in Israel, 2010-2019Regev Cohen, Talya Finn, Frida Babushkin, et al.
Journal of Fungi (Basel, Switzerland)|July 27, 2022
Invasive Fungal Diseases in Hospitalized Patients with COVID-19 in Israel: A Multicenter Cohort StudyMeital Elbaz, Maya Korem, Oshrat Ayalon, et al.
Open Forum Infectious Diseases|June 13, 2024
Varicella-Zoster Virus-Induced Neurologic Disease After COVID-19 Vaccination: A Multicenter Observational Cohort StudyMeital Elbaz, Tomer Hoffman, Dafna Yahav, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 11, 2022
Risk Factors and Multidimensional Assessment of Long Coronavirus Disease Fatigue: A Nested Case-Control StudyIli Margalit, Dana Yelin, Moshe Sagi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 16, 2026
Cat Scratch Disease Encephalitis: New Insights into Rate, Clinical Features, and Long-Term OutcomesMichal Yakubovsky, Laliv Kadar, Eugene Katchman, et al.
Frontiers in Medicine|July 12, 2021
Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 VaccinationKhitam Muhsen, Mitchell J Schwaber, Jihad Bishara, et al.
Emerging Infectious Diseases|June 22, 2023
Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021-2022Roni Biran, Regev Cohen, Talya Finn, et al.
The Journal of Infection|October 7, 2024
Recurrent Clostridioides difficile infections in solid organ transplant recipients: The international CALIPSO studyGiusy Tiseo, Dafna Yahav, Alaa Atamna, et al.
Cancer Medicine|February 24, 2024
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximabTali Shafat, Daniel Grupel, Tzvika Porges, et al.
Pageof 7